Understand the social drivers of patient access and outcomes
Go beyond traditional real-world data to understand why access and outcomes differ across populations in life sciences. Quantify and visualize patient and population-level risk exposure to reveal the non-clinical factors shaping outcomes.
See what you’re missing in our white paper
CASE STUDY
A life sciences organization used SocialScape® data to assess social risk across priority trial geographies before enrollment. In one high-priority ZIP code, 90% of residents faced elevated risk across multiple social domains:
Food Landscape Risk
88%
Health Literacy Risk
90%
Economic Climate Risk
74%
Without Broadband Access
75%
By overlaying trial sites with social risk and community resource maps, teams identified enrollment and retention barriers early, enabling precise recruitment and participant support planning.
You’ve quantified everything. Except social risk.
Clinical development and commercialization are more expensive and scrutinized than ever.
Yet a critical variable often goes unmeasured: the social factors shaping participation, adherence, therapy access, and real-world outcomes. Without this visibility, organizations face slower recruitment, higher dropout rates, uneven engagement, and barriers to treatment access after launch.
Socially Determined’s risk models integrate diverse data sources to generate person- and community-level risk scores.
Design research and access strategies around real-world barriers
Social risk enables life sciences teams to anticipate non-clinical barriers before they compromise recruitment, retention, adherence, or therapy access.
Design clinical trials around lived realities
Overlay clinical eligibility criteria with social risk insights to identify where transportation, affordability, or health literacy limit participation. Select sites more strategically and anticipate enrollment and retention risks before recruitment begins.
Improve recruitment and retention
Identify communities where support services can mitigate participation barriers. Design trial support programs that reflect real patient experience, improving representativeness and retention.
Strengthen market access and patient support
Quantify social drivers of treatment access challenges. Guide patient support investments and demonstrate real-world patient need to payers and policymakers.
Enhance RWE and RWD analysis
Incorporate social context into real-world data and utilization analyses to uncover insights that better explain patient behavior outside clinical settings.
A
competitive
edge
in commercial and clinical strategy
Socially Determined integrates social risk into clinical development, market access, and real-world strategy, turning patient-centric goals into measurable execution.
With SocialScape data, you can:
De-risk clinical development
Identify enrollment and retention barriers before launch to reduce operational friction and uncertainty.
Optimize commercial investment
Allocate patient support and access resources based on validated social drivers instead of assumptions.
Strengthen real-world evidence strategy
Incorporate social risk into RWD analysis to produce more complete, defensible outcome insights.
Integrate with your existing analytics ecosystem
SocialScape’s platform and person- and community-level data are designed to complement your existing RWD, claims, and clinical datasets. Our data integrates securely into enterprise workflows, enabling teams across clinical development, market access, HEOR, and patient support to incorporate social context and risk insights into decision-making.